Company Overview of Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.
Key Executives for Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.
|P. Kay Wagoner Ph.D.||No Relationships||Co-founder, Chief Executive Officer and President||68|
Icagen, Inc. Prior to Merger with XRpro Sciences, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Andrew Muratore||9 Relationships||Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.||43|
|Douglas E. Giordano||39 Relationships||Pfizer Inc.||54|
|Dhiren R. Thakker Ph.D.||21 Relationships||Chesson Laboratory Associates, Inc.||--|
|Roy Swaringen Ph.D.||16 Relationships||Asymchem Laboratories, Inc.||--|
|John E. Dillberger DVM, Ph.D., DACVP, DABT, FIATP||20 Relationships||Krenitsky Pharmaceuticals Inc.||--|
Icagen, Inc. Prior to Merger with XRpro Sciences, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$334.2K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.